Clinical Experiences with Budipine in Parkinson Therapy
Editat de F. Gerstenbrand, Werner Poewe, G. Sternen Limba Engleză Paperback – 31 ian 1985
Preț: 715.19 lei
Preț vechi: 752.83 lei
-5% Nou
Puncte Express: 1073
Preț estimativ în valută:
136.86€ • 142.02$ • 114.40£
136.86€ • 142.02$ • 114.40£
Carte tipărită la comandă
Livrare economică 18 martie-01 aprilie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783540137641
ISBN-10: 3540137645
Pagini: 228
Ilustrații: XI, 213 p.
Dimensiuni: 178 x 254 x 12 mm
Greutate: 0.4 kg
Editura: Springer Berlin, Heidelberg
Colecția Springer
Locul publicării:Berlin, Heidelberg, Germany
ISBN-10: 3540137645
Pagini: 228
Ilustrații: XI, 213 p.
Dimensiuni: 178 x 254 x 12 mm
Greutate: 0.4 kg
Editura: Springer Berlin, Heidelberg
Colecția Springer
Locul publicării:Berlin, Heidelberg, Germany
Public țintă
ResearchCuprins
James Parkinson and the Treatment of His Disease.- Biochemical Neuropathology: A New Approach to Parkinson’s Disease.- Clinical Neurophysiology of Parkinson’s Disease.- Dopaminergic Agonists and Receptors: Their Relevance to the Treatment of Parkinson’s Disease.- Brain Dopaminergic Receptor Changes in Parkinson’s Disease in Relation to the Disease Process and Treatment.- Analysis of Akinesia.- Observations of Voluntarily Induced Automatic Motor Behaviour in Parkinsonism.- Significance of Mental Disorders in the Long-Term Treatment of Parkinson’s Disease.- Treatment of Parkinson’s Disease in Early and Late Phases.- Relevance of Dopaminergic Agonists and Antagonists to Parkinsonian Tremor.- Therapeutic Possibilities in On-Off Phenomena in Parkinson’s Disease.- Target and Additive Drugs in the Treatment of Parkinson’s Disease: A Pilot Study.- Pharmacologic Bases of Antiparkinsonian Therapy.- The Pharmacodynamics of Budipine on Central Neurotransmitter Systems.- Biochemical and Pharmacologic Aspects of the Mechanism of Action of Budipine.- Pharmacokinetics and Metabolism of Budipine in Animals and Humans.- Clinical Experience with Budipine in Parkinsonian Therapy.- Controlled Single-Blind Trial of Budipine. L-Dopa, and Amantadine in 102 Patients with Parkinson’s Disease.- Open Clinical Trial of Budipine in 25 Tremor-Dominant Parkinsonian Patients.- Effect of Budipine on Parkinsonian Tremor Resistant to Other Antiparkinsonian Medication.- Budipine: A New Chemical Substance in the Treatment of Parkinson’s Disease.- Observations on the Therapeutic Effect of Budipine on Parkinson’s Disease.- Long-Term Treatment with Budipine.- Budipine Treatment of Neuroleptic-Induced Parkinsonism.- Randomized Double-Blind Trial of Budipine and Biperiden in Patients with Neuroleptic Extrapyramidal Symptoms.- The Effect of Budipine on the Rheology of the Blood.- EMG and Computer Analysis of Patients with Tremor and Rigidity Under Budipine Therapy.- Vigilance Study Using Electrooculographic and Electroencephalographic Methods After Acute Budipine Administration in Healthy Subjects.- Budipine in the Treatment of Extrapyramidal Disorders Not Related to Parkinson’s Disease.